Significant detection of new germline pathogenic variants in Australian Pancreatic Cancer Screening Program participants
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1897-4287
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Significant detection of new germline pathogenic variants in Australian Pancreatic Cancer Screening Program participants ; volume:19 ; number:1 ; day:16 ; month:8 ; year:2021 ; pages:1-14 ; date:12.2021
Hereditary cancer in clinical practice ; 19, Heft 1 (16.8.2021), 1-14, 12.2021
- Urheber
-
Murali, Krithika
Dwarte, Tanya M.
Nikfarjam, Mehrdad
Tucker, Katherine M.
Vaughan, Rhys B.
Efthymiou, Marios
Collins, Allison
Spigelman, Allan D.
Salmon, Lucinda
Johns, Amber L.
Williams, David B.
Delatycki, Martin B.
John, Thomas
Stoita, Alina
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13053-021-00190-1
- URN
-
urn:nbn:de:101:1-2021112220053235594610
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:34 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Murali, Krithika
- Dwarte, Tanya M.
- Nikfarjam, Mehrdad
- Tucker, Katherine M.
- Vaughan, Rhys B.
- Efthymiou, Marios
- Collins, Allison
- Spigelman, Allan D.
- Salmon, Lucinda
- Johns, Amber L.
- Williams, David B.
- Delatycki, Martin B.
- John, Thomas
- Stoita, Alina
- SpringerLink (Online service)
Ähnliche Objekte (12)
Correction to: Significant detection of new germline pathogenic variants in Australian Pancreatic Cancer Screening Program participants
Clinically significant germline pathogenic variants are missed by tumor genomic sequencing
Characterization of pathogenic germline mutations in human Protein Kinases
Potential pathogenic germline variant reporting from tumor comprehensive genomic profiling complements classic approaches to germline testing
Germline biallelic BRCA2 pathogenic variants and medulloblastoma: an international cohort study
Unusual phenotypes in patients with a pathogenic germline variant in DICER1
Unusual phenotypes in patients with a pathogenic germline variant in DICER1
Prevalence of pathogenic germline variants in the circulating tumor DNA testing
Evolutionary origin of germline pathogenic variants in human DNA mismatch repair genes
Reduced penetrance BRCA1 and BRCA2 pathogenic variants in clinical germline genetic testing
Genetic testing and management of prostate cancer patients with pathogenic germline variants
Germline pathogenic variants in RNF43 in patients with and without serrated polyposis syndrome
Correction to: Significant detection of new germline pathogenic variants in Australian Pancreatic Cancer Screening Program participants
Clinically significant germline pathogenic variants are missed by tumor genomic sequencing
Characterization of pathogenic germline mutations in human Protein Kinases
Potential pathogenic germline variant reporting from tumor comprehensive genomic profiling complements classic approaches to germline testing
Germline biallelic BRCA2 pathogenic variants and medulloblastoma: an international cohort study
Unusual phenotypes in patients with a pathogenic germline variant in DICER1
Unusual phenotypes in patients with a pathogenic germline variant in DICER1
Prevalence of pathogenic germline variants in the circulating tumor DNA testing
Evolutionary origin of germline pathogenic variants in human DNA mismatch repair genes
Reduced penetrance BRCA1 and BRCA2 pathogenic variants in clinical germline genetic testing
Genetic testing and management of prostate cancer patients with pathogenic germline variants
Germline pathogenic variants in RNF43 in patients with and without serrated polyposis syndrome
Correction to: Significant detection of new germline pathogenic variants in Australian Pancreatic Cancer Screening Program participants
Clinically significant germline pathogenic variants are missed by tumor genomic sequencing
Characterization of pathogenic germline mutations in human Protein Kinases
Potential pathogenic germline variant reporting from tumor comprehensive genomic profiling complements classic approaches to germline testing
Germline biallelic BRCA2 pathogenic variants and medulloblastoma: an international cohort study
Unusual phenotypes in patients with a pathogenic germline variant in DICER1
Unusual phenotypes in patients with a pathogenic germline variant in DICER1
Prevalence of pathogenic germline variants in the circulating tumor DNA testing
Evolutionary origin of germline pathogenic variants in human DNA mismatch repair genes
Reduced penetrance BRCA1 and BRCA2 pathogenic variants in clinical germline genetic testing
Genetic testing and management of prostate cancer patients with pathogenic germline variants